Silverarc Capital Management LLC purchased shares of Scholar Rock Holding Co.
Silverarc Capital Management LLC purchased 9,711 shares of Scholar Rock Holding Co. (NASDAQ:SRRK) for a $69,000 investment in Q3. Other investors, such as Royal Bank of Canada and Amalgamated Bank, also increased their stakes in SRRK. Silverarc has holdings in various biotech companies, including Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics, and Viridian Therapeutics.
February 18, 2024
15 Articles